Marumo Nkomo: The WTO Medicines Decision in light of its Utilization - Taschenbuch
ISBN: 9783838373607
[ED: Taschenbuch], [PU: LAP Lambert Acad. Publ.], Neuware - Paragraph 6 of the Doha Declaration on the TRIPS Agreement and Public Health (Doha Declaration) mandated World Trade Organizati… Mehr…
[ED: Taschenbuch], [PU: LAP Lambert Acad. Publ.], Neuware - Paragraph 6 of the Doha Declaration on the TRIPS Agreement and Public Health (Doha Declaration) mandated World Trade Organization (WTO) Members to devise a solution for countries whose dearth in pharmaceutical manufacturing capacity rendered them unable to effectively use compulsory licensing as a public interest tool. Two years later, WTO Members followed on from Doha by creating a special mechanism to allow Members with sufficiently strong pharmaceutical sectors to issue compulsory licenses for the sole purpose of export to paragraph 6 countries. The formal name for this Mechanism is the Decision on the Implementation of Paragraph 6 of the Doha Declaration on the TRIPS Agreement and Public Health however it is colloquially known inter alia as the 30 August decision. Five years on from the adoption of the 30 August decision, only one example of its utilization exists, that of Canada (as exporter) and Rwanda (as importer). This book restates the background to the 30 August decision and adds to the existing literature analysing it in order to assess how effective it is likely to prove in addressing the paragraph 6 mandate..., DE, [SC: 2.00], Neuware, gewerbliches Angebot, 222x151x12 mm, 80, [GW: 132g], PayPal, offene Rechnung, Banküberweisung, sofortueberweisung.de, Expédition internationale<
The WTO Medicines Decision in light of its Utilization - Resolution or Resignation? - Taschenbuch
2010, ISBN: 9783838373607
[ED: Taschenbuch / Paperback], [PU: LAP Lambert Academic Publishing], Paragraph 6 of the Doha Declaration on the TRIPS Agreement and Public Health (Doha Declaration) mandated World Trade … Mehr…
[ED: Taschenbuch / Paperback], [PU: LAP Lambert Academic Publishing], Paragraph 6 of the Doha Declaration on the TRIPS Agreement and Public Health (Doha Declaration) mandated World Trade Organization (WTO) Members to devise a solution for countries whose dearth in pharmaceutical manufacturing capacity rendered them unable to effectively use compulsory licensing as a public interest tool. Two years later, WTO Members followed on from Doha by creating a special mechanism to allow Members with sufficiently strong pharmaceutical sectors to issue compulsory licenses for the sole purpose of export to paragraph 6 countries. The formal name for this Mechanism is the Decision on the Implementation of Paragraph 6 of the Doha Declaration on the TRIPS Agreement and Public Health however it is colloquially known inter alia as the 30 August decision. Five years on from the adoption of the 30 August decision, only one example of its utilization exists, that of Canada (as exporter) and Rwanda (as importer). This book restates the background to the 30 August decision and adds to the existing literature analysing it in order to assess how effective it is likely to prove in addressing the paragraph 6 mandate..., [SC: 0.00], Neuware, gewerbliches Angebot<
booklooker.de
Syndikat Buchdienst Versandkosten:Versandkostenfrei, Versand nach Deutschland (EUR 0.00) Details...
(*) Derzeit vergriffen bedeutet, dass dieser Titel momentan auf keiner der angeschlossenen Plattform verfügbar ist.
Marumo Nkomo: The WTO Medicines Decision in light of its Utilization - Taschenbuch
ISBN: 9783838373607
[ED: Taschenbuch], [PU: LAP Lambert Acad. Publ.], Neuware - Paragraph 6 of the Doha Declaration on the TRIPS Agreement and Public Health (Doha Declaration) mandated World Trade Organizati… Mehr…
[ED: Taschenbuch], [PU: LAP Lambert Acad. Publ.], Neuware - Paragraph 6 of the Doha Declaration on the TRIPS Agreement and Public Health (Doha Declaration) mandated World Trade Organization (WTO) Members to devise a solution for countries whose dearth in pharmaceutical manufacturing capacity rendered them unable to effectively use compulsory licensing as a public interest tool. Two years later, WTO Members followed on from Doha by creating a special mechanism to allow Members with sufficiently strong pharmaceutical sectors to issue compulsory licenses for the sole purpose of export to paragraph 6 countries. The formal name for this Mechanism is the Decision on the Implementation of Paragraph 6 of the Doha Declaration on the TRIPS Agreement and Public Health however it is colloquially known inter alia as the 30 August decision. Five years on from the adoption of the 30 August decision, only one example of its utilization exists, that of Canada (as exporter) and Rwanda (as importer). This book restates the background to the 30 August decision and adds to the existing literature analysing it in order to assess how effective it is likely to prove in addressing the paragraph 6 mandate..., [SC: 0.00], Neuware, gewerbliches Angebot, 222x151x12 mm, [GW: 132g]<
booklooker.de
Mein Buchshop Versandkosten:Versandkostenfrei, Versand nach Deutschland (EUR 0.00) Details...
(*) Derzeit vergriffen bedeutet, dass dieser Titel momentan auf keiner der angeschlossenen Plattform verfügbar ist.
Marumo Nkomo: The WTO Medicines Decision in light of its Utilization - Taschenbuch
2010, ISBN: 383837360X
[EAN: 9783838373607], Neubuch, [PU: LAP Lambert Acad. Publ. Jul 2010], Neuware - Paragraph 6 of the Doha Declaration on the TRIPS Agreement and Public Health (Doha Declaration) mandated W… Mehr…
[EAN: 9783838373607], Neubuch, [PU: LAP Lambert Acad. Publ. Jul 2010], Neuware - Paragraph 6 of the Doha Declaration on the TRIPS Agreement and Public Health (Doha Declaration) mandated World Trade Organization (WTO) Members to devise a solution for countries whose dearth in pharmaceutical manufacturing capacity rendered them unable to effectively use compulsory licensing as a public interest tool. Two years later, WTO Members followed on from Doha by creating a special mechanism to allow Members with sufficiently strong pharmaceutical sectors to issue compulsory licenses for the sole purpose of export to paragraph 6 countries. The formal name for this Mechanism is the Decision on the Implementation of Paragraph 6 of the Doha Declaration on the TRIPS Agreement and Public Health; however it is colloquially known inter alia as the 30 August decision. Five years on from the adoption of the 30 August decision, only one example of its utilization exists, that of Canada (as exporter) and Rwanda (as importer). This book restates the background to the 30 August decision and adds to the existing literature analysing it in order to assess how effective it is likely to prove in addressing the paragraph 6 mandate. 80 pp. Englisch<
AbeBooks.de
Rheinberg-Buch, Bergisch Gladbach, Germany [53870650] [Rating: 5 (von 5)] NEW BOOK Versandkosten:Versandkostenfrei (EUR 0.00) Details...
(*) Derzeit vergriffen bedeutet, dass dieser Titel momentan auf keiner der angeschlossenen Plattform verfügbar ist.
Marumo Nkomo: The WTO Medicines Decision in light of its Utilization - neues Buch
ISBN: 9783838373607
Paragraph 6 of the Doha Declaration on the TRIPS Agreement and Public Health (Doha Declaration) mandated World Trade Organization (WTO) Members to devise a solution for countries whose de… Mehr…
Paragraph 6 of the Doha Declaration on the TRIPS Agreement and Public Health (Doha Declaration) mandated World Trade Organization (WTO) Members to devise a solution for countries whose dearth in pharmaceutical manufacturing capacity rendered them unable to effectively use compulsory licensing as a public interest tool. Two years later, WTO Members followed on from Doha by creating a special mechanism to allow Members with sufficiently strong pharmaceutical sectors to issue compulsory licenses for the sole purpose of export to paragraph 6 countries. The formal name for this Mechanism is the Decision on the Implementation of Paragraph 6 of the Doha Declaration on the TRIPS Agreement and Public Health; however it is colloquially known inter alia as the 30 August decision. Five years on from the adoption of the 30 August decision, only one example of its utilization exists, that of Canada (as exporter) and Rwanda (as importer). This book restates the background to the 30 August decision and adds to the existing literature analysing it in order to assess how effective it is likely to prove in addressing the paragraph 6 mandate... Bücher / Sozialwissenschaften, Recht & Wirtschaft / Recht<
Dodax.de
Nr. 57c43dd99c345609084ee168 Versandkosten:Versandkosten: 0.0 EUR, Lieferzeit: 6 Tage, DE. (EUR 0.00) Details...
(*) Derzeit vergriffen bedeutet, dass dieser Titel momentan auf keiner der angeschlossenen Plattform verfügbar ist.
The WTO Medicines Decision in light of its Utilization - Taschenbuch
ISBN: 9783838373607
[ED: Taschenbuch], [PU: LAP Lambert Acad. Publ.], Neuware - Paragraph 6 of the Doha Declaration on the TRIPS Agreement and Public Health (Doha Declaration) mandated World Trade Organizati… Mehr…
[ED: Taschenbuch], [PU: LAP Lambert Acad. Publ.], Neuware - Paragraph 6 of the Doha Declaration on the TRIPS Agreement and Public Health (Doha Declaration) mandated World Trade Organization (WTO) Members to devise a solution for countries whose dearth in pharmaceutical manufacturing capacity rendered them unable to effectively use compulsory licensing as a public interest tool. Two years later, WTO Members followed on from Doha by creating a special mechanism to allow Members with sufficiently strong pharmaceutical sectors to issue compulsory licenses for the sole purpose of export to paragraph 6 countries. The formal name for this Mechanism is the Decision on the Implementation of Paragraph 6 of the Doha Declaration on the TRIPS Agreement and Public Health however it is colloquially known inter alia as the 30 August decision. Five years on from the adoption of the 30 August decision, only one example of its utilization exists, that of Canada (as exporter) and Rwanda (as importer). This book restates the background to the 30 August decision and adds to the existing literature analysing it in order to assess how effective it is likely to prove in addressing the paragraph 6 mandate..., DE, [SC: 2.00], Neuware, gewerbliches Angebot, 222x151x12 mm, 80, [GW: 132g], PayPal, offene Rechnung, Banküberweisung, sofortueberweisung.de, Expédition internationale<
The WTO Medicines Decision in light of its Utilization - Resolution or Resignation? - Taschenbuch
2010, ISBN: 9783838373607
[ED: Taschenbuch / Paperback], [PU: LAP Lambert Academic Publishing], Paragraph 6 of the Doha Declaration on the TRIPS Agreement and Public Health (Doha Declaration) mandated World Trade … Mehr…
[ED: Taschenbuch / Paperback], [PU: LAP Lambert Academic Publishing], Paragraph 6 of the Doha Declaration on the TRIPS Agreement and Public Health (Doha Declaration) mandated World Trade Organization (WTO) Members to devise a solution for countries whose dearth in pharmaceutical manufacturing capacity rendered them unable to effectively use compulsory licensing as a public interest tool. Two years later, WTO Members followed on from Doha by creating a special mechanism to allow Members with sufficiently strong pharmaceutical sectors to issue compulsory licenses for the sole purpose of export to paragraph 6 countries. The formal name for this Mechanism is the Decision on the Implementation of Paragraph 6 of the Doha Declaration on the TRIPS Agreement and Public Health however it is colloquially known inter alia as the 30 August decision. Five years on from the adoption of the 30 August decision, only one example of its utilization exists, that of Canada (as exporter) and Rwanda (as importer). This book restates the background to the 30 August decision and adds to the existing literature analysing it in order to assess how effective it is likely to prove in addressing the paragraph 6 mandate..., [SC: 0.00], Neuware, gewerbliches Angebot<
- Versandkosten:Versandkostenfrei, Versand nach Deutschland (EUR 0.00) Syndikat Buchdienst
Marumo Nkomo: The WTO Medicines Decision in light of its Utilization - Taschenbuch
ISBN: 9783838373607
[ED: Taschenbuch], [PU: LAP Lambert Acad. Publ.], Neuware - Paragraph 6 of the Doha Declaration on the TRIPS Agreement and Public Health (Doha Declaration) mandated World Trade Organizati… Mehr…
[ED: Taschenbuch], [PU: LAP Lambert Acad. Publ.], Neuware - Paragraph 6 of the Doha Declaration on the TRIPS Agreement and Public Health (Doha Declaration) mandated World Trade Organization (WTO) Members to devise a solution for countries whose dearth in pharmaceutical manufacturing capacity rendered them unable to effectively use compulsory licensing as a public interest tool. Two years later, WTO Members followed on from Doha by creating a special mechanism to allow Members with sufficiently strong pharmaceutical sectors to issue compulsory licenses for the sole purpose of export to paragraph 6 countries. The formal name for this Mechanism is the Decision on the Implementation of Paragraph 6 of the Doha Declaration on the TRIPS Agreement and Public Health however it is colloquially known inter alia as the 30 August decision. Five years on from the adoption of the 30 August decision, only one example of its utilization exists, that of Canada (as exporter) and Rwanda (as importer). This book restates the background to the 30 August decision and adds to the existing literature analysing it in order to assess how effective it is likely to prove in addressing the paragraph 6 mandate..., [SC: 0.00], Neuware, gewerbliches Angebot, 222x151x12 mm, [GW: 132g]<
- Versandkosten:Versandkostenfrei, Versand nach Deutschland (EUR 0.00) Mein Buchshop
Marumo Nkomo: The WTO Medicines Decision in light of its Utilization - Taschenbuch
2010, ISBN: 383837360X
[EAN: 9783838373607], Neubuch, [PU: LAP Lambert Acad. Publ. Jul 2010], Neuware - Paragraph 6 of the Doha Declaration on the TRIPS Agreement and Public Health (Doha Declaration) mandated W… Mehr…
[EAN: 9783838373607], Neubuch, [PU: LAP Lambert Acad. Publ. Jul 2010], Neuware - Paragraph 6 of the Doha Declaration on the TRIPS Agreement and Public Health (Doha Declaration) mandated World Trade Organization (WTO) Members to devise a solution for countries whose dearth in pharmaceutical manufacturing capacity rendered them unable to effectively use compulsory licensing as a public interest tool. Two years later, WTO Members followed on from Doha by creating a special mechanism to allow Members with sufficiently strong pharmaceutical sectors to issue compulsory licenses for the sole purpose of export to paragraph 6 countries. The formal name for this Mechanism is the Decision on the Implementation of Paragraph 6 of the Doha Declaration on the TRIPS Agreement and Public Health; however it is colloquially known inter alia as the 30 August decision. Five years on from the adoption of the 30 August decision, only one example of its utilization exists, that of Canada (as exporter) and Rwanda (as importer). This book restates the background to the 30 August decision and adds to the existing literature analysing it in order to assess how effective it is likely to prove in addressing the paragraph 6 mandate. 80 pp. Englisch<
- NEW BOOK Versandkosten:Versandkostenfrei (EUR 0.00) Rheinberg-Buch, Bergisch Gladbach, Germany [53870650] [Rating: 5 (von 5)]
Marumo Nkomo: The WTO Medicines Decision in light of its Utilization - neues Buch
ISBN: 9783838373607
Paragraph 6 of the Doha Declaration on the TRIPS Agreement and Public Health (Doha Declaration) mandated World Trade Organization (WTO) Members to devise a solution for countries whose de… Mehr…
Paragraph 6 of the Doha Declaration on the TRIPS Agreement and Public Health (Doha Declaration) mandated World Trade Organization (WTO) Members to devise a solution for countries whose dearth in pharmaceutical manufacturing capacity rendered them unable to effectively use compulsory licensing as a public interest tool. Two years later, WTO Members followed on from Doha by creating a special mechanism to allow Members with sufficiently strong pharmaceutical sectors to issue compulsory licenses for the sole purpose of export to paragraph 6 countries. The formal name for this Mechanism is the Decision on the Implementation of Paragraph 6 of the Doha Declaration on the TRIPS Agreement and Public Health; however it is colloquially known inter alia as the 30 August decision. Five years on from the adoption of the 30 August decision, only one example of its utilization exists, that of Canada (as exporter) and Rwanda (as importer). This book restates the background to the 30 August decision and adds to the existing literature analysing it in order to assess how effective it is likely to prove in addressing the paragraph 6 mandate... Bücher / Sozialwissenschaften, Recht & Wirtschaft / Recht<
- Nr. 57c43dd99c345609084ee168 Versandkosten:Versandkosten: 0.0 EUR, Lieferzeit: 6 Tage, DE. (EUR 0.00)
1Da einige Plattformen keine Versandkonditionen übermitteln und diese vom Lieferland, dem Einkaufspreis, dem Gewicht und der Größe des Artikels, einer möglichen Mitgliedschaft der Plattform, einer direkten Lieferung durch die Plattform oder über einen Drittanbieter (Marketplace), etc. abhängig sein können, ist es möglich, dass die von eurobuch angegebenen Versandkosten nicht mit denen der anbietenden Plattform übereinstimmen.
Paragraph 6 of the Doha Declaration on the TRIPS Agreement and Public Health (Doha Declaration) mandated World Trade Organization (WTO) Members to devise a solution for countries whose dearth in pharmaceutical manufacturing capacity rendered them unable to effectively use compulsory licensing as a public interest tool. Two years later, WTO Members followed on from Doha by creating a special mechanism to allow Members with sufficiently strong pharmaceutical sectors to issue compulsory licenses for the sole purpose of export to paragraph 6 countries. The formal name for this Mechanism is the Decision on the Implementation of Paragraph 6 of the Doha Declaration on the TRIPS Agreement and Public Health; however it is colloquially known inter alia as the 30 August decision. Five years on from the adoption of the 30 August decision, only one example of its utilization exists, that of Canada (as exporter) and Rwanda (as importer). This book restates the background to the 30 August decision and adds to the existing literature analysing it in order to assess how effective it is likely to prove in addressing the paragraph 6 mandate...
Detailangaben zum Buch - The WTO Medicines Decision in light of its Utilization
EAN (ISBN-13): 9783838373607 ISBN (ISBN-10): 383837360X Gebundene Ausgabe Taschenbuch Erscheinungsjahr: 2010 Herausgeber: LAP Lambert Acad. Publ. 80 Seiten Gewicht: 0,132 kg Sprache: eng/Englisch
Buch in der Datenbank seit 2007-10-26T09:42:15+02:00 (Vienna) Detailseite zuletzt geändert am 2017-08-11T07:45:23+02:00 (Vienna) ISBN/EAN: 9783838373607
ISBN - alternative Schreibweisen: 3-8383-7360-X, 978-3-8383-7360-7 Alternative Schreibweisen und verwandte Suchbegriffe: Titel des Buches: let there light
